All News #Library
Biotech
Rubedo Life Sciences Reports Promising Phase 1 Results
26 Mar 2026 //
PHARMIWEB
Rubedo Life Sciences, SVAX Partner Strategically At FII Week
30 Oct 2025 //
BUSINESSWIRE
Rubedo Life Sciences Clears FDA for RLS-1496 in Actinic Keratosis
17 Sep 2025 //
PHARMAWEB
Rubedo Life Sciences Doses First Patient with Lead Drug RLS-1496
22 May 2025 //
BUSINESSWIRE
Rubedo Life Sciences Appoints Dr. Frederick Beddingfield III as CEO
11 Nov 2024 //
BUSINESSWIRE

Market Place
Sourcing Support